OBESTOP COMBINATION PRODUCT CAPSULES

Indications

• Obesity
• Weight management
• Appetite suppression

Dosage

Children: Refer to specific product guidelines, as safety and efficacy in children have not been well-established.

Adults: Refer to specific product guidelines, as dosages can vary widely between formulations.

Mechanism of action

The primary mechanism of action of HCA involves the inhibition of the enzyme ATP-citrate lyase, which plays a key role in the conversion of carbohydrates into fats. By inhibiting this enzyme, HCA may help to reduce fat storage and promote fat oxidation. Additionally, HCA is believed to increase serotonin levels in the brain, which may help to reduce appetite and cravings.

Pharmacodynamics

HCA has been shown to influence metabolic processes by promoting fat oxidation and reducing lipogenesis (fat creation). This can lead to weight reduction and may improve lipid profiles by lowering triglycerides and cholesterol levels. The appetite-suppressing effects are thought to be mediated through increased serotonin, which can enhance mood and reduce emotional eating.

Pharmacokinetics

HCA is absorbed in the gastrointestinal tract after oral administration. Its bioavailability can be affected by food intake. The metabolism of HCA primarily occurs in the liver, where it may undergo conjugation, and it is excreted via the urine. The half-life of HCA is not well-established, and further studies are needed to fully elucidate its pharmacokinetic profile.

Adverse effects

• Gastrointestinal upset
• Nausea
• Headache
• Dizziness
• Dry mouth

Interactions

• May interact with medications for diabetes, potentially leading to hypoglycemia
• Possible interaction with anticoagulants, increasing the risk of bleeding

Precautions

• Use with caution in patients with diabetes
• Should be avoided in patients with liver or kidney disease
• Not recommended for pregnant or breastfeeding women without medical advice

Pregnancy

Limited data is available; use is not recommended due to potential risks.

Breast-feeding

Not enough reliable information is available; use with caution.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Formulations

• Capsules
• Tablets
• Powder

Indications

• Pain relief
• Inflammation reduction
• Antimicrobial treatment
• Oral health maintenance
• Wound healing support
• Digestive aid

Dosage

Children: Refer to herbal medicine guidelines for specific dosing recommendations as no standard dosing is established.

Adults: Refer to herbal medicine guidelines for specific dosing recommendations as no standard dosing is established.

Mechanism of action

Myrrh contains compounds such as sesquiterpenes, which exhibit anti-inflammatory properties by inhibiting the production of pro-inflammatory cytokines. Additionally, myrrh has been shown to possess antimicrobial activity, likely due to the presence of essential oils that can disrupt microbial cell membranes.

Pharmacodynamics

The pharmacodynamics of myrrh involve its ability to modulate inflammation and provide analgesic effects. Its active constituents can exert effects on pain pathways, thereby reducing discomfort. The antimicrobial properties contribute to the prevention of infection in wounds and oral applications.

Pharmacokinetics

The pharmacokinetics of myrrh are not extensively studied in humans. However, it is known that the active compounds are absorbed through the gastrointestinal tract when ingested. Myrrh is metabolized in the liver, and its effects may be influenced by individual variations in metabolism. The duration of action can vary based on the formulation and route of administration.

Adverse effects

• Gastrointestinal upset
• Allergic reactions
• Skin irritation

Precautions

• Use with caution in individuals with allergies to similar compounds

Pregnancy

Insufficient data available on safety during pregnancy. Use only if clearly needed.

Breast-feeding

Limited information available. Consult a healthcare provider before use.

Storage

Store in a cool, dry place away from direct sunlight.

Formulations

• Resin
• Extract
• Essential oil

Indications

• Herbal medicine for various ailments
• Nutritional supplementation
• Flavoring agents in food
• Support for digestive health
• Management of stress and anxiety

Dosage

Children: Paediatric dosing is dependent on the specific extract and should be determined based on the product guidelines or consulting a healthcare professional familiar with herbal medicine.

Adults: Dosage varies widely based on the specific extract and condition being treated. Refer to product-specific guidelines or consult relevant pharmacological literature for appropriate dosing.

Mechanism of action

The mechanism of action of extracts varies depending on the source material and the specific compounds present. Common mechanisms include modulation of neurotransmitter systems, anti-inflammatory effects, antioxidant activity, and interaction with various cellular pathways. For example, flavonoids in plant extracts may exert antioxidant effects by scavenging free radicals, while alkaloids may influence neurotransmitter receptors.

Pharmacodynamics

The pharmacodynamics of extracts depends on their composition. They may exhibit various effects, such as anti-inflammatory, analgesic, antimicrobial, and immunomodulatory activities. The pharmacological effects are often dose-dependent, with lower doses providing therapeutic benefits and higher doses potentially leading to adverse effects. The time course of action can also vary, with some extracts providing rapid relief and others requiring chronic use to achieve efficacy.

Pharmacokinetics

The pharmacokinetics of extracts depend on the specific compounds and their properties, including solubility, stability, and absorption. Typically, active constituents are absorbed in the gastrointestinal tract and may undergo first-pass metabolism in the liver. The distribution of compounds can vary, affecting their bioavailability and the duration of action. Elimination routes may include renal excretion or metabolic conversion to inactive forms.

Pregnancy

Safety during pregnancy varies depending on the specific extract. Consult specific extract guidelines.

Breast-feeding

Safety during breastfeeding varies depending on the specific extract. Consult specific extract guidelines.

Storage

Store in a cool, dry place away from direct sunlight, and keep out of reach of children.

Indications

• Diabetes mellitus
• Hyperlipidemia
• Digestive disorders
• Inflammatory conditions

Dosage

Children: There is insufficient established dosing information for pediatric populations. Consult relevant pediatric dosing references for guidance.

Adults: Refer to established guidelines and clinical protocols for specific dosing. Generally, fenugreek is available in various forms, including capsules, powders, and teas, with common dosages ranging from 5 to 30 grams of seeds per day.

Mechanism of action

Fenugreek exerts its effects primarily through its active components, including saponins, alkaloids, and flavonoids. These compounds may enhance insulin sensitivity and stimulate insulin secretion, thereby aiding in the management of blood glucose levels. Additionally, fenugreek may influence lipid metabolism, potentially leading to improvements in cholesterol levels. Its anti-inflammatory properties may be attributed to the modulation of inflammatory pathways, including the inhibition of pro-inflammatory cytokines.

Pharmacodynamics

The pharmacodynamic effects of fenugreek include improvements in glucose metabolism, lipid profile, and gastrointestinal health. The soluble fiber content may aid in slowing gastric emptying, promoting satiety, and improving bowel regularity. Fenugreek's anti-inflammatory properties may help alleviate symptoms of inflammatory conditions and contribute to overall health improvement.

Pharmacokinetics

The pharmacokinetics of fenugreek are not fully elucidated. However, it is known that the active constituents are absorbed in the gastrointestinal tract, with bioavailability influenced by the method of preparation and consumption. The onset of action can vary, with effects on blood glucose levels observed within a few hours post ingestion.

Adverse effects

• Allergic reactions
• Gastrointestinal disturbances
• Hypoglycemia

Interactions

• May enhance the effects of anticoagulants
• Potential interaction with antidiabetic medications

Precautions

• Use with caution in individuals with hormone-sensitive conditions
• Monitor blood glucose levels in diabetic patients

Pregnancy

Safety during pregnancy is not established; consult a healthcare provider.

Breast-feeding

Consult a healthcare provider before use while breastfeeding.

Storage

Store in a cool, dry place away from direct sunlight.

Formulations

• Seeds
• Extracts
• Capsules

Indications

• Weight management
• Appetite suppression
• Cholesterol control

Dosage

Children: Refer to specific product guidelines as no standard paediatric dose is established.

Adults: Refer to specific product guidelines as no standard adult dose is established.

Mechanism of action

Hydroxycitric acid (HCA), the primary active compound in Garcinia, is believed to inhibit the enzyme citrate lyase, which plays a crucial role in the conversion of carbohydrates to fats. By blocking this enzyme, HCA may reduce the synthesis of fatty acids and cholesterol, thereby promoting weight loss. Additionally, HCA may increase serotonin levels in the brain, which could help reduce appetite and improve mood.

Pharmacodynamics

The pharmacodynamic effects of Garcinia are primarily associated with its ability to modulate lipid metabolism. HCA's action on citrate lyase inhibits fat storage, potentially leading to decreased body weight and fat mass. Some studies suggest that HCA may also enhance glycogen synthesis, which can provide an energy source and improve physical performance. However, the clinical significance of these effects varies, and results from studies have been inconsistent.

Pharmacokinetics

Garcinia extracts containing HCA are typically absorbed in the gastrointestinal tract after oral administration. The bioavailability of HCA can be influenced by factors such as food intake and the specific formulation of the supplement. Metabolism of HCA occurs primarily in the liver, and it is excreted in urine. The half-life of HCA has not been well established in humans, and further research is needed to fully elucidate its pharmacokinetic profile.

Adverse effects

• Gastrointestinal upset
• Headache
• Nausea
• Diarrhea
• Dry mouth

Interactions

• May interact with medications for diabetes, potentially affecting blood sugar levels
• Could interact with anticoagulants, increasing the risk of bleeding

Precautions

• Caution in patients with diabetes, as it may affect blood glucose levels
• Use with caution in individuals with a history of liver disease
• Not recommended for use in pregnant or breastfeeding women without medical advice

Pregnancy

There is insufficient data on the safety of garcinia during pregnancy. It is best avoided unless prescribed by a healthcare professional.

Breast-feeding

There is limited information on the excretion of garcinia in human milk. Caution is advised.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Formulations

• Capsules
• Tablets
• Powder

Indications

• Diabetes management
• Hyperlipidemia
• Digestive disorders
• Appetite stimulation
• Lactation support

Dosage

Children: Refer to pediatric guidelines for specific dosage recommendations based on the child's condition and age.

Adults: Refer to professional guidelines for specific dosage recommendations based on the condition being treated.

Mechanism of action

Fenugreek exerts its effects mainly through its active compounds. It is believed to enhance insulin sensitivity and stimulate insulin secretion, which aids in blood sugar regulation. Additionally, fenugreek may influence lipid metabolism and reduce cholesterol absorption in the gastrointestinal tract. The presence of 4-hydroxyisoleucine, an amino acid derivative, is particularly noted for its role in modulating insulin release.

Pharmacodynamics

The pharmacodynamic effects of fenugreek are attributed to its ability to interact with various metabolic pathways. Its saponins can inhibit the absorption of cholesterol and triglycerides, thereby contributing to lipid-lowering effects. Furthermore, fenugreek's anti-inflammatory and antioxidant properties may improve overall metabolic health and reduce the risk of chronic diseases.

Pharmacokinetics

The pharmacokinetics of fenugreek are not extensively studied, but it is understood that the active compounds are absorbed in the gastrointestinal tract. Once absorbed, they may exert systemic effects, although the exact bioavailability and half-life of fenugreek constituents vary. The metabolism of fenugreek compounds likely occurs in the liver, leading to various metabolites that exert biological effects.

Pregnancy

There is insufficient evidence regarding the safety of graecum during pregnancy. Consult a healthcare provider before use.

Breast-feeding

The effects of graecum during breastfeeding are not well studied. It is advisable to consult a healthcare provider before use.

Storage

Store in a cool, dry place, away from direct sunlight. Keep out of reach of children.

Indications

• Hyperlipidemia
• Osteoarthritis
• Rheumatoid arthritis
• Weight management
• Thyroid disorders

Dosage

Children: Refer to established guidelines and consult a healthcare professional for appropriate dosing.

Adults: Refer to established guidelines and consult a healthcare professional for appropriate dosing.

Mechanism of action

Mukul exerts its effects mainly through its active component, guggulsterone, which is known to activate the farnesoid X receptor (FXR). This action leads to a decrease in cholesterol synthesis and an increase in the clearance of triglycerides. Guggulsterone also has anti-inflammatory properties, which may contribute to its effectiveness in inflammatory conditions.

Pharmacodynamics

Mukul exhibits lipid-modulating effects, reducing total cholesterol and triglyceride levels while increasing high-density lipoprotein (HDL) cholesterol. Its anti-inflammatory properties may help alleviate pain and swelling associated with conditions like arthritis. The effects may vary based on the formulation and concentration of guggulsterone present in the product.

Pharmacokinetics

The pharmacokinetics of mukul are not extensively studied, but it is known that guggulsterone is metabolized in the liver. The absorption and bioavailability can be influenced by various factors, including the formulation used. It is generally well-tolerated, although some individuals may experience gastrointestinal upset or allergic reactions.

Pregnancy

The safety of mukul during pregnancy is not well established. It is advisable to avoid use unless clearly needed.

Breast-feeding

The excretion of mukul in human breast milk is not known. Caution is advised when administering to nursing mothers.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Indications

• Gastrointestinal disorders
• Respiratory issues
• Anti-inflammatory treatment
• Pain relief
• Antioxidant support

Dosage

Children: Due to the potential toxicity of certain parts of the nigrum plant, pediatric dosing should be approached with caution and under medical supervision. It is recommended to refer to established pediatric guidelines for specific dosing information.

Adults: Dosing for nigrum varies depending on the preparation and specific condition being treated. Generally, it is advised to consult with a healthcare professional for appropriate dosing based on individual needs.

Mechanism of action

Nigrum contains several bioactive compounds, including alkaloids, glycosides, and flavonoids. These compounds are believed to exert their effects through various biochemical pathways, including modulation of neurotransmitter activity, inhibition of inflammatory cytokines, and antioxidant activity, which may contribute to its therapeutic properties.

Pharmacodynamics

The pharmacodynamic effects of nigrum are primarily due to its active constituents that interact with various receptors and enzymes in the body. The anti-inflammatory properties are thought to arise from the inhibition of cyclooxygenase (COX) enzymes and the modulation of nitric oxide production. Additionally, nigrum may have analgesic and sedative effects, attributed to its interaction with the central nervous system.

Pharmacokinetics

The pharmacokinetics of nigrum have not been extensively studied. However, it is known that the bioavailability of plant extracts can vary based on the method of preparation and individual metabolism. Generally, the absorption, distribution, metabolism, and excretion of its active compounds will depend on factors such as the specific preparation used and the individual's physiological characteristics.

Pregnancy

The safety of nigrum during pregnancy has not been established. Use with caution and only if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

It is not known whether nigrum is excreted in human milk. Caution is advised when administering to breastfeeding mothers.

Storage

Store in a cool, dry place, away from direct sunlight. Keep out of reach of children.

Indications

• Uncomplicated malaria caused by Plasmodium falciparum

Dosage

Children: Refer to the BNF for Children for appropriate dosing in paediatric patients.

Adults: Refer to the BNF for specific dosing recommendations.

Mechanism of action

Piperaquine acts by interfering with the heme detoxification process in the malaria parasite. It accumulates within the food vacuole of the parasite and inhibits the conversion of toxic heme into non-toxic hemozoin. This accumulation of free heme leads to oxidative stress and cellular damage, ultimately resulting in the death of the parasite.

Pharmacodynamics

Piperaquine demonstrates a dose-dependent response in its antimalarial activity. It is effective against the asexual blood stages of Plasmodium species, with a prolonged half-life that allows for once-weekly dosing in some regimens. The drug's efficacy is influenced by the rate of parasite clearance and the patient's immune response.

Pharmacokinetics

Piperaquine is well-absorbed following oral administration, with peak plasma concentrations typically occurring within 4 to 6 hours. It has a long elimination half-life, which can range from 10 to 30 days, allowing for sustained plasma levels. The drug is metabolized in the liver and excreted primarily in the feces, with a smaller fraction eliminated in the urine. Its pharmacokinetics can be significantly affected by drug interactions, particularly those that alter hepatic metabolism.

Interactions

• grapefruit juice: Severe (increases concentration)
• mitotane: Severe (decreases concentration)
• St. John's wort: Severe (decreases concentration)
• rifampicin: Severe (decreases concentration)
• dronedarone: Unknown (increases concentration)
• cobicistat: Unknown (increases concentration)
• crizotinib: Unknown (increases concentration)
• idelalisib: Unknown (increases concentration)
• imatinib: Unknown (increases concentration)
• letermovir: Unknown (increases concentration)

Pregnancy

Consult with a healthcare professional regarding the use of piper during pregnancy.

Breast-feeding

Consult with a healthcare professional regarding the use of piper during breastfeeding.

Storage

Store in a cool, dry place, away from direct sunlight.

Formulations

• {'name': 'Piperaquine', 'class': 'Penicillins', 'molecular_formula': 'C38H36N4O4'}

Indications

• Type 2 diabetes mellitus
• Digestive disorders
• Increased appetite
• Inflammatory conditions

Dosage

Children: Refer to established guidelines; specific dosages should be evaluated based on age, weight, and clinical condition.

Adults: Refer to established guidelines; specific dosages may vary based on the formulation and intended use.

Mechanism of action

The active components of fenugreek, such as 4-hydroxyisoleucine, are thought to enhance insulin secretion from the pancreas and improve glucose uptake in peripheral tissues. This action aids in lowering blood glucose levels. Fenugreek also contains saponins and flavonoids that exhibit anti-inflammatory and antioxidant properties, contributing to its overall health benefits.

Pharmacodynamics

Fenugreek's pharmacodynamic effects are primarily attributed to its ability to modulate glucose metabolism and improve insulin sensitivity. The soluble fiber in fenugreek seeds may slow carbohydrate absorption in the intestines, leading to lower postprandial blood glucose levels. Additionally, its anti-inflammatory properties may help reduce inflammation in chronic diseases such as diabetes.

Pharmacokinetics

The pharmacokinetics of fenugreek are not extensively studied; however, it is known that the active compounds are absorbed in the gastrointestinal tract after ingestion. The metabolism and excretion of these compounds are likely influenced by individual variations in gut microbiota and enzyme activity. Fenugreek's effects may vary based on the form used (e.g., seeds, powder, extract) and the dosage.

Adverse effects

• Gastrointestinal upset
• Diarrhea
• Allergic reactions
• Hypoglycemia

Interactions

• May potentiate the effects of anticoagulants
• May interact with antidiabetic medications, requiring dose adjustments

Precautions

• Use with caution in patients with diabetes
• Monitor blood sugar levels in diabetic patients
• Allergic reactions may occur in sensitive individuals

Pregnancy

Trigonella is considered possibly unsafe during pregnancy due to potential hormonal effects and effects on uterine contractions.

Breast-feeding

Trigonella is generally considered safe during breastfeeding, but consult a healthcare provider for individual advice.

Storage

Store in a cool, dry place away from direct sunlight.

Formulations

• Seeds
• Powder
• Extracts